Primary Myelofibrosis clinical trials at UC Cancer

• Connect® Myeloid Disease Registry

  open to eligible people ages 18 years and up

  The purpose of the Connect® Myeloid disease registry is to provide unique insights into treatment decisions and treatment patterns as they relate to clinical outcomes of patients with myeloid diseases in routine clinical practice. This disease registry will also evaluate molecular and cellular markers that may provide further prognostic classification which may or may not be predictive of therapy and clinical outcomes.

  at UCSD

Last updated: March 30, 2021